Recombinant Escherichia coli O157:H7 tRNA dimethylallyltransferase (miaA)

What are the alternative designations for the miaA gene in E. coli?

The miaA gene has been referred to by several alternative designations in the scientific literature, including:

• trpX (an early designation)

• tRNA(i6A37) synthase (functional description)

• Gene ID: EG10595 (EcoCyc database)

• b4171 and ECK4167 (alternative locus designations)

These various designations reflect both historical naming conventions and functional characterizations of the gene product throughout the history of E. coli genetic research.

What is the genomic context and structural characteristics of the miaA gene in E. coli O157:H7?

The miaA gene in E. coli K-12 substr. MG1655 (closely related to O157:H7) is:

• Located at position 4,399,252 → 4,400,202 (94.78 centisomes, 341°) on the chromosome

• Consists of 951 base pairs encoding a protein of 316 amino acids

• The protein is localized in the cytosol

The gene product functions as a monomeric enzyme, unlike some other tRNA modification enzymes that operate as multimeric complexes. This structural characteristic has important implications for its catalytic mechanism and interactions with substrate tRNAs .

What are the optimal methods for purifying recombinant E. coli O157:H7 tRNA dimethylallyltransferase?

Recombinant E. coli tRNA dimethylallyltransferase can be purified to apparent homogeneity using the following methodologies:

Three-step purification protocol:

• Ion-exchange chromatography using DE52 resin

• Mono-Q ion-exchange chromatography

• Size exclusion chromatography

Alternative two-step protocol for affinity-tagged enzyme:

• Ion-exchange chromatography

• Immunoaffinity chromatography using anti-tubulin antibodies (when enzyme contains a C-terminal tripeptide alpha-tubulin epitope)

The addition of a C-terminal tripeptide alpha-tubulin epitope to DMAPP-tRNA transferase does not affect the activity of the enzyme, making this an excellent approach for obtaining highly purified enzyme with minimal steps .

What are the kinetic parameters of purified tRNA dimethylallyltransferase?

The purified recombinant enzyme exhibits the following kinetic parameters:

The enzyme requires Mg²⁺ for activity and exhibits a broad pH optimum. These parameters demonstrate the high affinity of the enzyme for its tRNA substrate and suggest an ordered sequential mechanism for substrate binding .

How can researchers prepare suitable tRNA substrates for studying MiaA activity?

To obtain appropriate undermodified tRNA substrates for studying MiaA activity, researchers should follow this methodological approach:

• Generate a miaA-deficient strain of E. coli through gene knockout or mutation

• Transform this strain with an expression vector containing the gene for the desired tRNA (e.g., tRNA⁽ᴾʰᵉ⁾)

• Induce overexpression of the tRNA gene

• Extract total tRNA using acid-phenol extraction

• Perform anion-exchange chromatography to isolate the specific tRNA species

• Confirm the absence of the i⁶A37 modification using mass spectrometry or other analytical techniques

• Verify the functionality of the purified tRNA with in vitro binding assays

This approach ensures that the tRNA substrate lacks the specific modification catalyzed by MiaA, making it suitable for enzymatic studies and allowing accurate measurement of enzyme activity .

How should researchers design experiments to investigate the role of miaA in E. coli O157:H7 pathogenesis?

A comprehensive experimental design to investigate miaA's role in pathogenesis should include:

• Genetic manipulation:

  • Generate precise miaA deletion mutants in E. coli O157:H7 using allelic exchange

  • Create complemented strains by reintroducing the wild-type gene on a plasmid

  • Develop point mutants affecting specific catalytic residues

• Phenotypic characterization:

  • Compare growth rates in standard media and under stress conditions

  • Assess acid resistance patterns (critical for O157:H7 survival)

  • Evaluate adhesion to epithelial cells and colonization potential

  • Measure Shiga toxin production using quantitative assays

• In vivo studies:

  • Use animal models to assess colonization and virulence

  • Compare shedding patterns between wild-type and mutant strains

  • Evaluate tissue tropism and pathological changes

• Molecular analysis:

  • Perform transcriptomic and proteomic comparisons

  • Quantify specific virulence factor expression

  • Analyze tRNA modification profiles using LC-MS/MS

This multifaceted approach allows researchers to establish causal relationships between miaA function and specific virulence phenotypes in E. coli O157:H7 .

What techniques are appropriate for analyzing tRNA modifications in wild-type versus miaA mutant strains?

Analysis of tRNA modifications requires specialized techniques:

• Liquid chromatography-mass spectrometry (LC-MS):

  • Digest total tRNA with nucleases to release individual nucleosides

  • Separate nucleosides by reverse-phase chromatography

  • Identify and quantify modifications by mass spectrometry

  • Compare modification profiles between wild-type and mutant strains

• High-resolution gel electrophoresis:

  • Separate individual tRNA species on denaturing polyacrylamide gels

  • Detect mobility shifts caused by the absence of modifications

  • Quantify the relative abundance of different tRNA species

• Northern blot analysis with specific probes:

  • Design probes complementary to specific tRNAs

  • Hybridize to separated tRNAs on membranes

  • Measure abundance and integrity of target tRNAs

• Primer extension analysis:

  • Use reverse transcriptase to extend primers bound to tRNAs

  • Identify modification sites by detecting RT stops or pauses

  • Map the precise locations of modifications

These techniques provide complementary information about the nature and extent of tRNA modifications, allowing researchers to fully characterize the effects of miaA mutations on the tRNA modification landscape .

How can researchers resolve contradictory findings regarding miaA function across different E. coli strains?

When confronted with contradictory findings regarding miaA function across different E. coli strains, researchers should implement a systematic approach:

• Comprehensive genetic analysis:

  • Sequence the miaA gene and regulatory regions from all strains under study

  • Identify any polymorphisms or structural variations

  • Analyze the genomic context of miaA in each strain

• Standardized experimental conditions:

  • Use identical growth conditions and media formulations

  • Standardize assay protocols and analytical methods

  • Control for growth phase effects by using synchronized cultures

• Cross-complementation studies:

  • Express miaA variants from different strains in a common genetic background

  • Test whether phenotypic differences are due to the miaA gene itself or other factors

  • Create chimeric proteins to identify functional domains responsible for strain-specific effects

• Systems biology approach:

  • Perform comparative genomics to identify strain-specific factors that may interact with miaA

  • Use transcriptomics to identify differences in gene expression patterns

  • Develop predictive models that account for strain-specific differences

• Consider epistatic interactions:

  • Investigate potential interactions with strain-specific genetic elements

  • Examine the presence of suppressor mutations in different genetic backgrounds

  • Analyze potential regulatory differences affecting miaA expression

This methodical approach can help researchers determine whether differences in miaA function are due to intrinsic properties of the enzyme variants or contextual factors specific to each strain background .

What methods are most effective for studying the impact of miaA on codon-specific translation in E. coli O157:H7?

To study the impact of miaA on codon-specific translation, researchers should consider these specialized methodologies:

• Ribosome profiling:

  • Isolate ribosome-protected mRNA fragments

  • Sequence and map these fragments to the genome

  • Compare ribosome occupancy at specific codons between wild-type and miaA mutants

  • Identify translation pauses or inefficiencies at UNN codons specifically

• Reporter systems:

  • Design GFP or luciferase reporters enriched in specific codons

  • Measure expression levels in wild-type versus miaA mutant backgrounds

  • Create constructs with alternative synonymous codons to isolate codon-specific effects

• tRNA charging analysis:

  • Isolate total tRNA under acidic conditions to preserve aminoacylation

  • Perform northern blot analysis with probes specific for tRNAs modified by MiaA

  • Compare aminoacylation levels between wild-type and mutant strains

• Pulse-chase radiolabeling:

  • Measure incorporation rates of radiolabeled amino acids

  • Compare synthesis rates of proteins enriched in UNN codons

  • Analyze differences in translation kinetics between strains

• In vitro translation assays:

  • Prepare translation extracts from wild-type and miaA mutant strains

  • Test translation efficiency using mRNAs with defined codon content

  • Measure rates and fidelity of protein synthesis

These advanced techniques provide detailed insights into how miaA-catalyzed tRNA modifications affect translation at the level of individual codons, helping to elucidate the molecular basis for phenotypic changes observed in miaA mutants .

How does the miaA gene interact with stress response systems in E. coli O157:H7?

The interaction between miaA and stress response systems can be investigated through:

• Acid resistance analysis:

  • Test survival rates at different pH values (critical for O157:H7 pathogenesis)

  • Monitor expression of acid resistance genes (rpoS, adiA, gadA/B) in wild-type versus miaA mutants

  • Compare recovery rates after acid shock

• Oxidative stress response:

  • Challenge cultures with hydrogen peroxide or other oxidative agents

  • Measure expression and activity of detoxifying enzymes

  • Assess DNA and protein damage from oxidative stress

• Nutritional stress:

  • Evaluate growth in minimal media with limited nutrients

  • Test competitive fitness during nutrient limitation

  • Monitor stringent response activation through ppGpp measurements

• Comparative transcriptomics under stress conditions:

  • Perform RNA-seq under various stress conditions

  • Compare stress-induced transcriptional profiles between strains

  • Identify stress-response genes differentially regulated in miaA mutants

The potential role of tRNA modifications in modulating stress responses provides an important link between translation and bacterial adaptation to hostile environments, including those encountered during host colonization .

What innovative approaches can be used to target miaA for antimicrobial development against E. coli O157:H7?

Novel antimicrobial development strategies targeting miaA might include:

• Structure-based inhibitor design:

  • Use structural data to identify active site binding pockets

  • Design competitive inhibitors mimicking either DMAPP or tRNA substrates

  • Develop transition-state analogs that bind with high affinity

• High-throughput screening approaches:

  • Develop fluorescence-based assays for MiaA activity

  • Screen chemical libraries for inhibitory compounds

  • Validate hits using secondary biochemical assays

• Antisense/RNAi technologies:

  • Design antisense oligonucleotides targeting miaA mRNA

  • Develop RNA interference strategies to reduce miaA expression

  • Test effects on bacterial survival and virulence

• Combination therapy strategies:

  • Identify synergistic interactions between miaA inhibitors and conventional antibiotics

  • Test whether miaA inhibition sensitizes resistant strains to antibiotics

  • Evaluate potential for reduced resistance development

• Evaluation methods:

  • Measure minimum inhibitory concentrations (MICs) using standard protocols

  • Perform time-kill assays to assess bactericidal activity

  • Use animal models to evaluate efficacy in vivo

  • Test for development of resistance through serial passage experiments

Since tRNA modifications are essential for optimal bacterial growth and virulence, targeting miaA presents an intriguing strategy for developing novel antimicrobials against E. coli O157:H7 .

What detection methods are most sensitive for identifying E. coli O157:H7 strains with miaA mutations?

For identifying E. coli O157:H7 strains with miaA mutations, researchers should employ:

• PCR-based screening:

  • Design primers specific to conserved regions of miaA

  • Perform PCR amplification followed by Sanger sequencing

  • Use high-resolution melt analysis for rapid screening

• Restriction fragment length polymorphism (RFLP):

  • Identify restriction sites affected by common miaA mutations

  • Digest PCR products and analyze fragment patterns

  • Compare patterns with reference strains

• Whole genome sequencing:

  • Perform next-generation sequencing of isolates

  • Analyze sequence data for variants in miaA

  • Identify potential compensatory mutations elsewhere in the genome

• Phenotypic screening:

  • Test growth on media containing antibiotics that differentially affect miaA mutants

  • Develop colorimetric assays based on tRNA modification status

  • Use reporter systems sensitive to translational defects

• Immunomagnetic separation coupled with molecular detection:

  • Use antibody-coated magnetic beads to capture E. coli O157:H7 cells

  • Lyse captured cells and perform molecular analysis of the miaA gene

  • Combine with PCR or other nucleic acid amplification techniques

These methods can be adapted for both laboratory research and potential clinical/environmental screening applications, with varying levels of sensitivity and specificity .

What specialized equipment and reagents are required for studying tRNA modifications in E. coli O157:H7?

Specialized equipment and reagents for tRNA modification research include:

• For tRNA isolation and purification:

  • DEAE-cellulose or other ion-exchange resins

  • Size exclusion chromatography systems

  • Phenol:chloroform extraction reagents

  • Nuclease-free water and buffers

• For modification analysis:

  • HPLC systems with appropriate columns

  • Mass spectrometers (LC-MS/MS) capable of nucleoside analysis

  • Radioactive labeling reagents (³²P, ³H)

  • Thin-layer chromatography plates and tanks

• For enzyme characterization:

  • Fast protein liquid chromatography (FPLC) systems

  • Spectrophotometers for enzyme assays

  • Fluorescence plate readers for high-throughput screening

  • Thermal cyclers with real-time monitoring capabilities

• For substrate preparation:

  • In vitro transcription systems for producing unmodified tRNAs

  • Synthetic nucleoside standards for modified bases

  • Dimethylallyl diphosphate and other prenyl donors

  • Commercial tRNA samples as controls

• For structural studies:

  • Crystallization robotics and screening kits

  • X-ray diffraction equipment

  • NMR spectrometers for solution structure determination

  • Computational resources for molecular modeling

This specialized equipment represents a significant investment for laboratories focusing on tRNA modification research, highlighting the technical sophistication required in this field .

What are the common technical challenges in analyzing the effects of miaA mutations on bacterial virulence?

Researchers face several technical challenges when analyzing miaA effects on virulence:

• Avoiding secondary mutations:

  • miaA mutations may lead to selection for compensatory mutations

  • Careful strain construction and verification is essential

  • Whole genome sequencing should be used to confirm mutant integrity

• Controlling for growth defects:

  • miaA mutants often exhibit growth deficiencies

  • Normalizing virulence measurements to account for growth differences

  • Distinguishing direct virulence effects from general fitness costs

• Relevance of in vitro models:

  • Laboratory conditions poorly mimic host environments

  • Developing improved infection models that better reflect in vivo conditions

  • Validating findings in animal models when possible

• Isolating miaA-specific effects:

  • tRNA modifications affect global translation

  • Distinguishing direct effects from indirect consequences

  • Using complementation studies with site-directed mutants

• Standardization across studies:

  • Different growth conditions can affect outcomes

  • Strain background effects can confound results

  • Developing standardized protocols for virulence assessment